Start by identifying and remarketing existing winnerslike grilled chicken or saladswith clear nutritional information
Use of the injections started increasing in 2022, followed by "a sharp increase" in 2024
The experts shared how the pharmaceutical pipeline expands into new health indications, combinations of GLP-1 with other hormones, and more convenient delivery formats, while Ozempic, a semaglutide-based medication, is set to go off patent in several countries next year
2024;5:e214
No Insurance, No Waiting Rooms No Insurance, No Waiting Rooms Your Health, Simplified
Its now also available as a daily pill and as a higher-dose injectable version, Wegovy HD 7.2 mg, all made by the company Novo Nordisk